Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for BioLargo Inc have a median target of 0.42, with a high estimate of 0.45 and a low estimate of 0.38. The median estimate represents a 72.34% increase from the last price of 0.2437.
High | 84.7% | 0.45 |
Med | 72.3% | 0.42 |
Low | 55.9% | 0.38 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +22.50% |
Average growth rate | +49.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +40.65% |
Average growth rate | +107.85% |
More ▼